{"slug":"api-magentlab-com-api-calc-imwg-myeloma-a4d297","title":"IMWG 2014 myeloma requiring therapy (Rajkumar 2014)","host":"api.magentlab.com","method":"POST","resource":"https://api.magentlab.com/api/calc/imwg_myeloma","category":"other","description":"IMWG 2014 myeloma requiring therapy (Rajkumar 2014). Met when clonal BMPC ≥10% or biopsy-proven plasmacytoma plus ≥1 MDE: hypercalcemia, renal insufficiency, anemia, osteolytic lesion (CRAB), or BMPC ≥60%, involved:uninvolved FLC ratio ≥100 with involved FLC ≥100 mg/L, or >1 focal MRI lesion ≥5 mm (","price_listed":0.005,"price_asked":0.007,"state":"overcharges","state_label":"Asked 1.4x its listed price for its own example","checks_7d":1,"answered_7d":1,"latency_ms_median":313,"reported_calls_30d":0,"reported_payers_30d":0,"networks":["eip155:8453"],"badge":"unverified","paid_checks_7d":0,"paid_ok_7d":0,"example_input":{"body":{"items":[{"anemia":false,"bmpc_ge_60":false,"clonal_bmpc_ge_10_or_plasmacytoma":true,"flc_ratio_ge_100":false,"hypercalcemia":true,"mri_gt_1_focal":false,"osteolytic_lesion":false,"renal_insufficiency":false},{"anemia":false,"bmpc_ge_60":false,"clonal_bmpc_ge_10_or_plasmacytoma":true,"flc_ratio_ge_100":false,"hypercalcemia":true,"mri_gt_1_focal":false,"osteolytic_lesion":false,"renal_insufficiency":false}]},"method":"POST","type":"http"},"output_schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"anemia":{"description":"Anemia as assigned by the caller (Rajkumar 2014 CRAB): hemoglobin value >20 g/L below the lower limit of normal or hemoglobin <100 g/L. true or false. magent does not assay hemoglobin.","type":"boolean"},"bmpc_ge_60":{"description":"Clonal bone marrow plasma cells ≥60%, as assigned by the caller (Rajkumar 2014 SLiM). true or false. magent does not read a marrow.","type":"boolean"},"clonal_bmpc_ge_10_or_plasmacytoma":{"description":"Clonal bone marrow plasma cells ≥10% or biopsy-proven bony or extramedullary plasmacytoma, as assigned by the caller (Rajkumar 2014 IMWG entry for myeloma requiring therapy). true or false. When false, myeloma is false even if a myeloma-defining event is true. magent does not read a marrow or biopsy.","type":"boolean"},"flc_ratio_ge_100":{"description":"Involved:uninvolved serum free light-chain ratio ≥100 and involved free light chain ≥100 mg/L, as assigned by the caller as this one flag (Rajkumar 2014 SLiM). true or false. magent does not assay free light chains.","type":"boolean"},"hypercalcemia":{"description":"Hypercalcemia as assigned by the caller (Rajkumar 2014 CRAB): serum calcium >0.25 mmol/L (>1 mg/dL) above the upper limit of normal or >2.75 mmol/L (>11 mg/dL). true or false. magent does not assay calcium.","type":"boolean"},"mri_gt_1_focal":{"description":">1 focal lesion on MRI, each ≥5 mm, as assigned by the caller (Rajkumar 2014 SLiM). true or false. magent does not read MRI.","type":"boolean"},"osteolytic_lesion":{"description":"One or more osteolytic lesions on skeletal radiography, CT, or PET-CT, as assigned by the caller (Rajkumar 2014 CRAB). If marrow clonal plasma cells are <10%, more than one bone lesion is required to distinguish solitary plasmacytoma; that is the caller’s assignment of this flag. true or false. magent does not read imaging.","type":"boolean"},"renal_insufficiency":{"description":"Renal insufficiency as assigned by the caller (Rajkumar 2014 CRAB): creatinine clearance <40 mL/min or serum creatinine >177 µmol/L (>2 mg/dL). true or false. magent does not assay creatinine.","type":"boolean"}},"required":["clonal_bmpc_ge_10_or_plasmacytoma","hypercalcemia","renal_insufficiency","anemia","osteolytic_lesion","bmpc_ge_60","flc_ratio_ge_100","mri_gt_1_focal"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"},"history":[{"day":"2026-09-28","reachable":true,"status":402,"valid_402":true,"asked_usdc":0.007,"price_match":false,"latency_ms":313,"error":null}],"description_full":"IMWG 2014 myeloma requiring therapy (Rajkumar 2014). Met when clonal BMPC ≥10% or biopsy-proven plasmacytoma plus ≥1 MDE: hypercalcemia, renal insufficiency, anemia, osteolytic lesion (CRAB), or BMPC ≥60%, involved:uninvolved FLC ratio ≥100 with involved FLC ≥100 mg/L, or >1 focal MRI lesion ≥5 mm (SLiM). Not a diagnosis. Not smouldering MM, MGUS, POEMS, or amyloid. Not Greipp ISS or R-ISS. magent does not assay calcium, creatinine, hemoglobin, or FLC, and does not read MRI.","last_updated":"2026-09-28T15:12:54.131Z","schemes":["exact"]}